A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared with Placebo on Exercise-Induced Bronchoconstriction in Adult Patients with Asthma

Trial Identifier:	AZ-RU-00004
Sponsor:	AstraZeneca
Start Date:	December 2023
Primary Completion Date:	June 2024
Study Completion Date:	June 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Russian (Russia) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
RU	Moscow, RU, 105554
RU	Penza, RU, 440067
RU	Perm, RU, 614000
RU	Saint-Petersburg, RU, 192071
RU	Saratov, RU, 410054
RU	Ulyanovsk, RU, 432009

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company